Silybin/Silymarin treatment in chronic hepatitis C

Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 5

Abstract

Authors and Affiliations

Varenka Barbero-Becerra, Nahum Méndez-Sánchez

Keywords

Related Articles

Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients

Introduction. Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479). This phase 2, double-blind international trial eval...

Portal venous gas. Report of three cases

When portal venous gas (PVG) is found, it is usually considered an ominous sign. It is now more frequently found because of the improvement in imaging studies, mainly through computed tomography (CT). It was first relate...

Detection of hepatitis B activity in HBeAg-negative carriers with normal aminotransferase levels in central Brazil

Background and rationale for the study. Hepatitis B virus (HBV) chronic infection may follow a benigncourse with low risk of cirrhosis or liver cancer. As differentiation of inactive status from HBeAg-negative chronic he...

Download PDF file
  • EP ID EP78200
  • DOI -
  • Views 103
  • Downloads 0

How To Cite

Varenka Barbero-Becerra, Nahum Méndez-Sánchez (2012). Silybin/Silymarin treatment in chronic hepatitis C. Annals of Hepatology, 11(5), 731-733. https://europub.co.uk/articles/-A-78200